Search Bar & Filters
Found 1 Actively Recruiting clinical trials
Actively Recruiting
This research aims to evaluate whether a blood test measuring Neurofilament light chain NfL protein levels can help diagnose dementia in people presenting with cognitive complaints within a single healthcare network. The study addresses challenges in current dementia diagnosis, such as missed subtle changes, cultural and language barriers, and limited access to advanced brain imaging, especially in diverse and regional populations. The goal is to develop accessible diagnostic pathways that improve timely and accurate dementia diagnosis. Participants will have a one-time blood draw and speech test to measure brain protein levels and analyze voice acoustics. A follow-up at 12 months includes repeated speech tests and phone-based questionnaires and cognitive assessments. An optional genetic test using a saliva sample sent from home is available for those at risk of genetic dementia. These new technologies aim to create cost-effective and widely accessible diagnostic tools. During the study, participants undergo initial blood and speech testing, then are followed up at one year with phone assessments and repeated speech analysis. Researchers will track changes in speech and language processing alongside NfL levels. The study measures baseline NfL protein and changes in speech and language over time. This approach aims to shorten diagnosis time, increase certainty, and improve access to care and future therapies for people with dementia.